Market Analysis of Denosumab in the United StatesAugust 8, 2025 Overview Denosumab is an approved biological drug in the U.S. market, with a single reference…
Market Analysis of Qsymia in the USAAugust 7, 2025 The US market has 1 approved drug containing Phentermine Hydrochloride/Topiramate (Qsymia), developed by VIVUS, Inc. for the treatment of obesity and overweight conditions.…
